• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同胆碱能激动剂对海马M1毒蕈碱受体高亲和力和低亲和力状态的亲和力。

Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors.

作者信息

Potter L T, Ferrendelli C A

机构信息

Department of Pharmacology, University of Miami School of Medicine, Florida.

出版信息

J Pharmacol Exp Ther. 1989 Mar;248(3):974-8.

PMID:2539465
Abstract

The ability of 16 well-known cholinergic agonists to compete with 1 nM [3H]pirenzepine for the high (KH) and low (KL) affinity states of M1 muscarine receptors was studied, using rabbit hippocampal membranes suspended in 20 mM Tris buffer containing 1 mM MnCl2, at pH 7.4 and 25 degrees C. The hippocampus, like the cerebral cortex, has primarily m1 and m3 subtypes of M1 receptors; these receptors have very similar affinities for pirenzepine and for agonists, and both receptors are coupled to the activation of phospholipase C. KH values varied more than 10,000-fold, and did not correlate with prior measurements of the ability of agonists to promote cerebral excitation or phosphoinositide turnover in cortical tissue. KL values varied more than 1,000-fold, and also did not correlate with agonist activities. In contrast, KL/KH ratios for individual agonists varied from 66 for cis-dioxolane to near 1 for oxotremorine, and correlated closely with data concerning the relative physiological and biochemical effectiveness of the agonists. Each agonist showed only a single affinity in 0.2 mM guanyl-5'-yl imidodiphosphate. Thus binding measurements of KL/KH appear to be a new way to screen cholinergic agonists for relative efficacy at m1 or m3 receptors coupled to their native G proteins. Whereas both quaternary and tertiary agonists are known to activate M2 receptors, only the quaternary agents tested were highly effective M1 agonists. The five agonists which have been tested for improving human memory all appear to have low efficacy at M1 receptors.

摘要

在20 mM Tris缓冲液(含1 mM MnCl₂,pH 7.4,25℃)中悬浮的兔海马膜上,研究了16种知名胆碱能激动剂与1 nM [³H]哌仑西平竞争M1毒蕈碱受体高亲和力(KH)和低亲和力(KL)状态的能力。海马体与大脑皮层一样,主要有M1受体的m1和m3亚型;这些受体对哌仑西平和激动剂的亲和力非常相似,且两种受体均与磷脂酶C的激活偶联。KH值变化超过10000倍,且与先前测量的激动剂促进大脑皮层组织兴奋或磷酸肌醇周转的能力无关。KL值变化超过1000倍,也与激动剂活性无关。相比之下,各个激动剂的KL/KH比值从顺式二氧戊环的66到氧化震颤素的接近1不等,且与激动剂相对生理和生化效能的数据密切相关。每种激动剂在0.2 mM鸟苷-5'-基亚氨基二磷酸中仅表现出单一亲和力。因此,KL/KH的结合测量似乎是一种筛选胆碱能激动剂在与其天然G蛋白偶联的m1或m3受体上相对效能的新方法。虽然已知季铵和叔胺激动剂均可激活M2受体,但所测试的只有季铵类药物是高效的M1激动剂。已测试的用于改善人类记忆的五种激动剂在M1受体上似乎均具有低效性。

相似文献

1
Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors.不同胆碱能激动剂对海马M1毒蕈碱受体高亲和力和低亲和力状态的亲和力。
J Pharmacol Exp Ther. 1989 Mar;248(3):974-8.
2
Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.阿尔茨海默病中高亲和力激动剂与M1毒蕈碱受体结合的丧失:对胆碱能替代疗法失败的影响。
Ann Neurol. 1991 Mar;29(3):256-62. doi: 10.1002/ana.410290305.
3
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.[3H]哌仑西平和(-)-[3H]奎宁环基苯甲酸酯与大鼠大脑皮质和心脏毒蕈碱胆碱能位点的结合。I. 激动剂与假定毒蕈碱亚型结合的特性及调节
J Pharmacol Exp Ther. 1986 May;237(2):411-8.
4
Tetrahydroaminoacridine and other allosteric antagonists of hippocampal M1 muscarine receptors.四氢氨基吖啶及海马M1毒蕈碱受体的其他变构拮抗剂。
Mol Pharmacol. 1989 May;35(5):652-60.
5
Two affinity states of M1 muscarine receptors.M1毒蕈碱受体的两种亲和力状态。
Cell Mol Neurobiol. 1988 Jun;8(2):181-91. doi: 10.1007/BF00711244.
6
Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.通过抑制[3H]哌仑西平和[3H]喹核醇基苯甲酸酯与大鼠脑膜的结合来研究加拉明与毒蕈碱M1和M2受体的结合。
Mol Pharmacol. 1986 Jul;30(1):58-68.
7
[3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes.[3H]哌仑西平和(-)-[3H]东莨菪碱与大鼠大脑皮质及心脏毒蕈碱胆碱能位点的结合。II. 拮抗剂与假定毒蕈碱亚型结合的特性及调节
J Pharmacol Exp Ther. 1986 May;237(2):419-27.
8
Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists.人类M1、M2和M3毒蕈碱胆碱能受体:激动剂和拮抗剂的结合特性
J Neurol Sci. 1990 Jun;97(1):67-80. doi: 10.1016/0022-510x(90)90099-9.
9
Agonist binding to M1 muscarinic receptors is sensitive to guanine nucleotides.激动剂与M1毒蕈碱受体的结合对鸟嘌呤核苷酸敏感。
Eur J Pharmacol. 1989 Oct 17;172(4-5):363-72. doi: 10.1016/0922-4106(89)90017-5.
10
Effect of solubilization on the distinct binding properties of muscarine receptors from rabbit hippocampus and brainstem.
Mol Pharmacol. 1986 Sep;30(3):193-9.

引用本文的文献

1
Oligomerization of G protein-coupled receptors: past, present, and future.G蛋白偶联受体的寡聚化:过去、现在与未来
Biochemistry. 2004 Dec 21;43(50):15643-56. doi: 10.1021/bi047907k.
2
SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.SR 46559A:一种新型强效毒蕈碱化合物,无胆碱能综合征。
Psychopharmacology (Berl). 1993;112(2-3):219-27. doi: 10.1007/BF02244914.
3
Muscarinic receptor binding and activation of second messengers by substituted N-methyl-N-[4-(1-azacycloalkyl)-2-butynyl]acetamides.
取代的N-甲基-N-[4-(1-氮杂环烷基)-2-丁炔基]乙酰胺对毒蕈碱受体的结合及第二信使的激活作用
J Med Chem. 1991 Mar;34(3):1073-9. doi: 10.1021/jm00107a029.